Gilead

Gilead is a biopharmaceutical company that researches, develops, and sells drugs, including treatments for HIV and other diseases.

Why it’s in the news: It is in the news due to a recent legal victory in a California Supreme Court case and a controversial R&D deal with the Biden administration over HIV drug patents.

Latest on Gilead

• STAT+: Pharmalittle: We’re reading about a Lilly access program, a Gilead court victory, and more
• STAT+: California Supreme Court sides with Gilead in ‘duty’ to innovate case
• STAT+: Pharmalittle: We’re reading about Trump’s plan for tariffs on generics, a Merck and Gilead HIV pill, and more
• STAT+: AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents
• Vivatides gets $54M; Wegovy drops cold chain in EU; Gilead takes Kymera option

Connections

5 entities linked to Gilead across the news graph.